Shares of 111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) were up 2.4% during trading on Monday . The company traded as high as $8.41 and last traded at $8.38. Approximately 12,303 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 58,331 shares. The stock had previously closed at $8.18.
Analyst Ratings Changes
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of 111 in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.
View Our Latest Stock Analysis on YI
111 Trading Up 2.4%
111 (NASDAQ:YI – Get Free Report) last released its earnings results on Wednesday, December 17th. The company reported ($1.20) EPS for the quarter. The company had revenue of $421.49 million for the quarter.
About 111
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Further Reading
- Five stocks we like better than 111
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
